Adamis Pharmaceuticals Corp. (ADMP.OB) Influenza Vaccine Demonstrates Efficiency in Immunity against the Virus
Though it’s not getting the frenzy of media attention it received in the past several months, the World Health Organization and Center for Disease Control say the H1N1 (swine flu) is still spreading worldwide and remains a constant threat. Pharmaceutical companies are working to overcome modern challenges as the virus mutates, and are racing to develop and manufacture enough vaccines to protect citizens on mass scales. Adamis Pharmaceuticals Corp. operates through its two wholly owned subsidiaries as a specialty pharmaceutical company. The company today announced that its Adamis Viral Therapies subsidiary’s patented vaccine technology induces immunity against the influenza virus…